Hjem › Urotelial (overgangscelle) carcinom
Urotelial (overgangscelle) carcinom kliniske forsøg rekrutterer i USA
72 studier for Urotelial (overgangscelle) carcinom rekrutterer deltagere på steder over hele USA.
Byer med flest studier
- Nashville, TN23 studier
- New York City, NY22 studier
- Dallas, TX18 studier
- Edison, NJ18 studier
- Houston, TX18 studier
- Los Angeles, CA17 studier
- Queens, NY15 studier
- Chicago, IL14 studier
- Arlington, VA12 studier
- San Antonio, TX11 studier
- Boston, MA11 studier
- Austin, TX10 studier
- Orange, CA10 studier
- Philadelphia, PA9 studier
- Washington, DC9 studier
- Columbus, OH9 studier
- Baldwin Park, CA9 studier
- Atlanta, GA8 studier
- Cleveland, OH8 studier
- Jacksonville, FL8 studier
- Durham, NC8 studier
- Seattle, WA8 studier
- Irvine, CA8 studier
- Orlando, FL7 studier
- Omaha, NE7 studier
- Portland, OR7 studier
- San Francisco, CA7 studier
- St. Louis, MO7 studier
- New Rochelle, NY7 studier
- Staten Island, NY7 studier
- Greenburgh, NY7 studier
- Milwaukee, WI6 studier
- Denver, CO6 studier
- Phoenix, AZ6 studier
- New Haven, CT6 studier
- Detroit, MI6 studier
- Gainesville, FL6 studier
- Oklahoma City, OK6 studier
- Charlotte, NC6 studier
- Ann Arbor, MI6 studier
Efter delstat
- Alabama4 studier
- Arizona10 studier
- Arkansas5 studier
- Californien33 studier
- Colorado10 studier
- Connecticut7 studier
- District of Columbia7 studier
- Florida22 studier
- Georgia11 studier
- Idaho4 studier
- Illinois21 studier
- Indiana7 studier
- Iowa7 studier
- Kentucky4 studier
- Louisiana4 studier
- Maryland8 studier
- Massachusetts15 studier
- Michigan15 studier
- Minnesota7 studier
- Missouri10 studier
- Montana3 studier
- Nebraska7 studier
- Nevada3 studier
- New Jersey21 studier
- New York29 studier
- North Carolina15 studier
- Ohio17 studier
- Oklahoma8 studier
- Oregon8 studier
- Pennsylvania15 studier
- South Carolina8 studier
- South Dakota3 studier
- Tennessee25 studier
- Texas38 studier
- Utah6 studier
- Virginia21 studier
- Washington12 studier
- Wisconsin9 studier
Nyligt opdaterede studier
Officiel studietekst (engelsk)
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06270706Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06265285Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT05176483A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT06524544A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07090499Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma
Rekrutterer
Alder 19 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT06262516The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07285044Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07566156Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT03866382uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT05874921DBC-664 in Adult Patients With Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT07705035A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT05562830Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07421700A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07277413Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT06047379A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07218380Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT06439836Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 17. sep. 2026 · NCT05239624Gemcitabine and Carboplatin After Progression on Enfortumab Vedotin and Pembrolizumab in Advanced/Metastatic Urothelial Carcinoma
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 17. sep. 2026 · NCT07043972A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 16. sep. 2026 · NCT07532902GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 14. sep. 2026 · NCT04977453A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic Urothelial Carcinoma
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 11. sep. 2026 · NCT07815665A Study of GEN1106 in Participants With Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 10. sep. 2026 · NCT07416123A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 10. sep. 2026 · NCT06040762Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 10. sep. 2026 · NCT06293898Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.